A Phase I Study of IAG933 in Patients With Advanced Mesothelioma and Other Solid Tumors (NCT04857372)

🧪 Interventions in This Study

• IAG933 (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (16 Sites)

• University of California LA — Los Angeles, California
• Uni of Chi Medi Ctr Hema and Onco — Chicago, Illinois
• Massachusetts General Hospital — Boston, Massachusetts
• Cleveland Clinic Foundation — Cleveland, Ohio
• MD Anderson Cancer Center — Houston, Texas
• Novartis Investigative Site — Melbourne, Victoria
• Novartis Investigative Site — Montreal, Quebec
• Novartis Investigative Site — Villejuif,
• Novartis Investigative Site — Essen,
• Novartis Investigative Site — Milan, MI
• Novartis Investigative Site — Rozzano, MI
• Novartis Investigative Site — Chuo Ku, Tokyo
• Novartis Investigative Site — Rotterdam, South Holland
• Novartis Investigative Site — Barcelona,
• Novartis Investigative Site — Zurich,
• Novartis Investigative Site — Manchester,

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Mesothelioma

• Neoadjuvant Immune Checkpoint Blockade in Resectable Malignant Pleural Mesothelioma — Baltimore, Maryland
• Pleurectomy/Decortication (Neo) Adjuvant Chemotherapy and Intensity Modulated Radiation Therapy to the Pleura in Patients With Locally Advanced Malignant Pleural Mesothelioma — Tampa, Florida
• Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer — San Francisco, California
• Olaparib in Patients With HRD Malignant Mesothelioma — Chicago, Illinois
• A Study of Sacituzumab Govitecan in People With Mesothelioma — Basking Ridge, New Jersey

Explore by condition: All Mesothelioma clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.